-- (Updated to keep price target unchanged).
Harmony Biosciences (HRMY) has an average rating of overweight and mean price target of $43, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Price: $31.09, Change: $-0.07, Percent Change: -0.22%